Total Payments
$3,748
2024 Payments
$1,002
Companies
29
Transactions
198
Medicare Patients
13,880
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$3,748 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,748 | 198 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $761.41 | 50 | $0 (2024) |
| Lilly USA, LLC | $510.71 | 24 | $0 (2024) |
| Novo Nordisk Inc | $363.84 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $265.63 | 13 | $0 (2024) |
| Endologix LLC | $168.45 | 1 | $0 (2023) |
| Amgen Inc. | $140.43 | 6 | $0 (2024) |
| Esperion Therapeutics, Inc. | $132.65 | 8 | $0 (2024) |
| Exact Sciences Corporation | $131.95 | 7 | $0 (2024) |
| Boston Scientific Corporation | $125.08 | 6 | $0 (2024) |
| PFIZER INC. | $124.31 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,002 | 49 | ABBVIE INC. ($223.31) |
| 2023 | $1,149 | 53 | Lilly USA, LLC ($186.36) |
| 2022 | $733.59 | 43 | ABBVIE INC. ($237.02) |
| 2021 | $448.63 | 27 | AbbVie Inc. ($144.38) |
| 2020 | $167.30 | 11 | Merck Sharp & Dohme Corporation ($30.38) |
| 2019 | $74.93 | 4 | Boston Scientific Corporation ($42.56) |
| 2018 | $76.73 | 5 | Astellas Pharma US Inc ($37.09) |
| 2017 | $95.91 | 6 | GlaxoSmithKline, LLC. ($63.49) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: WOUND CARE | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Cardiology | ||||||
| 10/21/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.52 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 09/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Biological | ||||||
| 08/28/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: Hematology | ||||||
| 08/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: PAIN | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $23.04 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: PAIN | ||||||
| 06/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.30 | General |
| 06/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: WATCHMAN FLX_IC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 3,421 | 6,801 | $915,787 | $307,703 |
| 2022 | 29 | 3,533 | 6,630 | $896,502 | $294,480 |
| 2021 | 28 | 3,502 | 6,321 | $883,175 | $306,251 |
| 2020 | 26 | 3,424 | 6,463 | $891,169 | $271,265 |
Total Patients
13,880
Total Services
26,215
Medicare Billing
$1.2M
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 447 | 1,963 | $522,742 | $160,737 | 30.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 293 | 293 | $82,304 | $35,347 | 42.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 219 | 348 | $62,950 | $20,373 | 32.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 760 | 2,369 | $47,380 | $19,790 | 41.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 170 | 170 | $32,416 | $12,676 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 72 | $25,676 | $8,443 | 32.9% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 339 | 339 | $13,560 | $8,219 | 60.6% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 162 | 162 | $9,396 | $5,258 | 56.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 291 | 291 | $13,095 | $4,953 | 37.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 23 | $13,232 | $4,745 | 35.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 67 | 132 | $26,837 | $4,729 | 17.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 159 | 159 | $4,770 | $4,600 | 96.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 28 | 28 | $11,868 | $4,032 | 34.0% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 20 | 24 | $9,779 | $3,572 | 36.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 37 | 47 | $7,050 | $3,462 | 49.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 18 | 18 | $7,379 | $2,797 | 37.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 250 | 262 | $18,078 | $2,541 | 14.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $4,903 | $1,110 | 22.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 18 | 25 | $625.00 | $93.48 | 15.0% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 13 | 13 | $780.00 | $85.68 | 11.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 24 | 37 | $703.00 | $79.89 | 11.4% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 14 | 14 | $266.00 | $60.06 | 22.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 421 | 1,762 | $468,939 | $148,842 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 269 | 269 | $75,562 | $33,021 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 270 | 488 | $88,274 | $26,657 | 30.2% |
About Dr. John Sutterlin, MD
Dr. John Sutterlin, MD is a Family Medicine healthcare provider based in Goose Creek, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780636423.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sutterlin, MD has received a total of $3,748 in payments from pharmaceutical and medical device companies, with $1,002 received in 2024. These payments were reported across 198 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,748).
As a Medicare-enrolled provider, Sutterlin has provided services to 13,880 Medicare beneficiaries, totaling 26,215 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Goose Creek, SC
- Active Since 05/17/2006
- Last Updated 06/10/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1780636423
Products in Payments
- VRAYLAR (Drug) $404.86
- MOUNJARO (Drug) $290.44
- UBRELVY (Drug) $265.38
- Ozempic (Drug) $213.88
- NURTEC ODT (Drug) $183.05
- JARDIANCE (Drug) $169.95
- Ovation iX Iliac Stent Graft (Device) $168.45
- Cologuard Collection Kit (Device) $131.95
- Rybelsus (Drug) $130.98
- QULIPTA (Drug) $116.89
- TRULICITY (Drug) $112.10
- FARXIGA (Drug) $107.29
- BREZTRI (Drug) $100.94
- Repatha (Biological) $72.21
- NEXLIZET (Drug) $68.51
- NEXLETOL (Drug) $64.14
- MYRBETRIQ (Drug) $58.35
- COMIRNATY (Biological) $54.15
- REXULTI (Drug) $49.86
- SHINGRIX (Biological) $46.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goose Creek
Dr. Cayce Tangeman, M.d, M.D
Family Medicine — Payments: $134,587
Family Medicine $134,587
Dr. Donald Hanna, M.d, M.D
Family Medicine — Payments: $17,071
Family Medicine $17,071
Patricia Campbell, Md, MD
Family Medicine — Payments: $9,440
Family Medicine $9,440
Skye Deberry, Md, MD
Family Medicine — Payments: $6,567
Family Medicine $6,567
Dr. Sherry Viduya, Md, MD
Family Medicine — Payments: $5,588
Family Medicine $5,588
Dr. Joseph Nellis, D.o, D.O
Family Medicine — Payments: $1,486
Family Medicine $1,486